JKAMP

(redirected from JAMP)
Also found in: Acronyms.

JKAMP

A gene on chromosome 14q23.1 that encodes JNK1/MAPK8-associated membrane protein, which is thought regulate the duration of MAPK8 activity in response to various stress stimuli. JKAMP facilitates degradation of misfolded endoplasmic reticulum luminal proteins by recruiting components of the proteasome and endoplasmic reticulum-associated degradation (ERAD) system.
References in periodicals archive ?
(2007) examined Lattice-Boltzmann Method Benchmark and reported speed-up of around 6.1 on their proposed JaMP framework using 8 cores.
Another feature of the solutions is that they are equipped with a function to convert information on chemical substances contained in components that has been collected in a conventional JAMP format to a chemSHERPA format.
1998 Lari y Jamp' atu, ritual de lluvia y simbolismo andino en una escena de arte rupestre de Ariquilda 1.
As a way to address these issues, one of the SECs received a grant, Staff Education for Effective Collaboration in Southern Illinois: Building Teams for Student Success (JAMP, 2000), through the Illinois State Board of Education.
(15.) Samson RA, Houbraken JAMP, Kuijpers AFA, Frank JM, Frisvad JC.
Besides, Luminarie, Zestra is currently exclusively partnered with Orimed Pharma, the OTC subsidiary of Jamp Pharma in Canada, Densmore in France and Belgium, DanaLife ApS in select European markets including Denmark, Sothema Laboratories for the Middle East and North Africa, Elis Pharmaceuticals in Turkey and certain select markets including Lebanon, BioTask in Malaysia and J and H Co.
The company said that the improvements also make the information system compatible with JAMP MSDSplus (Ver 4), JAMP AIS (Ver 4) and JGPSSI (Ver 4.2) formats (due to be released), the latest industry-standard survey formats recommended by JAMP and JGPSSI.
Zestra is currently exclusively partnered with Orimed Pharma, the OTC subsidiary of Jamp Pharma in Canada, DanaLife ApS in select European markets, Sothema Laboratories for the Middle East and North Africa, Elis Pharmaceuticals in Turkey and certain select markets, Luminarie for Australia, New Zealand and the Philippines, BioTask in Malaysia and J and H Co.
It is currently exclusively partnered with Orimed Pharma, the OTC subsidiary of Jamp Pharma in Canada, Densmore Pharmaceutical International in France and Belgium, DanaLife ApS in select European markets, Sothema Laboratories for the Middle East and North Africa, Elis Pharmaceuticals in Turkey and certain select markets, Oz Biogenics for Myanmar and Vietnam, BioTask in Malaysia and Jand H Co.